Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (4): 65-70.doi: 10.6040/j.issn.1671-7554.0.2020.120

Previous Articles    

Clinical features of 51 patients with corona virus disease 2019

LEI Yu, LU Jing, GU Jiaying, ZHOU Dengfeng, LI Yuanyuan, LU Qiaofa   

  1. Department of Respiratory Medicine, Wuhan Fourth Hospital &
    Wuhan Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430033, Hubei, China
  • Published:2022-09-27

Abstract: Objective To investigate the clinical characteristics of corona virus disease 2019(COVID-19)patients in Wuhan City, and the correlation between inflammatory factors and severity. Methods According to the COVID-19 diagnosis and treatment plan(trial version fifth), the clinical data, including clinical symptoms, blood tests and chest CT, of 51 patients were retrospectively analyzed. The patients were divided into 3 groups: 32 cases of general type, 9 cases of severe type and 10 cases of critical type. Results (1) The main symptoms were fever(42 cases, 82.35%), cough, expectoration(39 cases, 76.47%), chest distress, shortness of breath(24 cases, 47.06%), diarrhea and headache(few cases); the accompanying symptoms included fatigue, muscle ache, headache, nausea, vomiting and diarrhea. The number of days before hospitalization was 1-21, with a median of 7; the number of days of hospitalization was 3-30, with a median of 12. (2) The results of peripheral blood generally showed that, CRP was increased(80.39%), lymphocyte count was decreased(68.63%), lactate dehydrogenase(LDH)was increased(52.94%), and the leukocyte count, neutrophil count, alanine transaminase(ALT), aspartate aminotransferase(AST), γ-glutamyl transpeptidase(γ-GT), total bilirubin(TBIL), direct bilirubin(DBIL), blood urea nitrogen(BUN)and creatinine(Cr)were normal. (3) The characteristics of chest CT showed that the foci were multiple in double lung and field lung, with mainly ground-glass opacity and patchy shadow, showing interstitial pneumonia change. During the course of the disease, the focus could increase, expand and increase in density, and did not form cavity. There was no pleural effusion change, and the focus was not easy to cause blockage of trachea and bronchi. (4) The lymphocyte count in general type was higher than those in severe type and critical type(H=3.656, P=0.001; H=5.572, P<0.001); the lymphocyte count showed no statistical difference between severe type and critical type(H=1.391, P=0.493). The CRP levels among the three groups were statistically different as a whole(F=5.220,P=0.009); The CRP level in critical type was higher than those in general type and severe type(both P<0.05), while that between general type and severe type exhibited no statistical difference(P>0.05). The LDH level in critical type was higher than that in general type(H=-2.961, P=0.009); Compared with the severe type, the LDH levels in general type and critical type exhibited no statistical difference(H=-1.051, P=0.879; H=-1.484, P=0.414). For leukocyte count, neutrophil count, ALT, AST, γ-GT, TBIL, DBIL, BUM, Cr expression levels, there existed no statistical difference after pairwise comparisons(P>0.05). Conclusion (1) Most of the COVID-19 patients are not severe at the initial stage of onset; the main symptoms are fever and cough, accompanied by gastrointestinal system or other systemic symptoms. (2) The levels of lymphocyte count, CRP and LDH are abnormal in severe patients, which may help to judge the severity of the disease.

Key words: Corona virus disease 2019, Lymphocyte, C-reactive protein, Lactate dehydrogenase, Clinical characteristics

CLC Number: 

  • R563.1
[1] 张文福, 何俊美, 帖金凤, 等. 冠状病毒的抵抗力与消毒[J]. 中国消毒学杂志, 2020,37(1): 63-67.
[2] Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China[J]. Nature, 2020, 579(7798): 265-269.
[3] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第6版)[EB/OL].(2020-02-19)[2020-02-23]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2. shtml.
[4] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019 [J]. N Engl J Med, 2020, 382(8): 727-733.
[5] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第5版)[EB/OL].(2020-02-04)[2020-02-06]. http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm.
[6] Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle[J]. J Med Virol, 2020, 92(4): 401-402.
[7] Hui DS, I Azhar E, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China[J]. Int J Infect Dis, 2020, 91: 264-266. doi: 10.1016/j.ijid.2020.01.009.
[8] World Health Organization. WHO Director-Generals remarks at the media briefing on 2019-nCoV on 11 February 2020[EB/OL].(2020-02-11)[2020-02-12]. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
[9] Tao Y, Shi M, Chommanard C, et al. Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history[J]. J Virol, 2017, 91(5). pii: e01953-16. doi: 10.1128/JVI.01953-16.
[10] Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses[J]. Nat Rev Microbiol, 2019, 17(3): 181-192.
[11] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. N Engl J Med, 2020, 382(13): 1199-1207.
[12] 国家卫生健康委办公厅,国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第5版 修正版)[EB/OL].(2020-02-09)[2020-02-10]. http://www.gov.cn/zhengce/zhengceku/2020-02/09/contene_5376406.htm.
[13] 靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)[J]. 解放军医学杂志, 2020, 45(1): 1-20. JIN Yinghui, CAI Lin, CHENG Zhenshun, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version)[J]. Medical Journal of Chinese Peoples Liberation Army, 2020, 45(1): 1-20.
[14] 华中科技大学同济医学院附属同济医院救治医疗专家组. 新型冠状病毒感染的肺炎诊疗快速指南(第3版)[J]. 医药导报, 2020: 1-9. doi:10.3870/j.issn.1004-0781.2020.03.001.
[15] 史河水,韩小雨,樊艳青,等.新型冠状病毒(2019-nCoV)感染的肺炎临床特征及影像学表现[J]. 临床放射学杂志, 2020. doi:10.13437/j.cnki.jcr.20200206.002. SHI Heshui, HAN Xiaoyu, FAN Yanqing, et al. Radiologic features of patients with 2019-nCoV infection[J]. Journal of Clinical Radiology, 2020. doi:10.13437/j.cnki.jcr.20200206.002.
[16] 雷子乔,史河水,梁波,等.新型冠状病毒(2019-nCoV)感染的肺炎的影像学检查与感染防控的工作方案[J].临床放射杂志, 2020. doi:10.13437/j.cnki.jcr.20200206.001.
[17] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506.
[18] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223): 507-513.
[19] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA,2020. doi: 10.1001/jama.2020.1585.
[20] Wong KT, Antonio GE, Hui DS, et al. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients[J]. Radiology, 2003, 228(2): 401-406.
[21] Jeffrey PK. Chest CT findings in 2019 novel coronavirus(2019-nCoV)infections from Wuhan, China: key points for the radiologist[J]. Radiology, 2020, 295(1): 16-17.
[22] 陈蕾,刘辉国,刘威,等.2019新型冠状病毒肺炎29例临床特征分析[J].中华结核和呼吸杂志,2020, 43(2): E005.
[23] Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score[J]. Front Microbiol, 2019, 10: 2752. doi:10.3389/fmicb.2019.02752.
[1] ZHANG Feng, WU Zhe, XU Jun, LIU Yulan. Changes of intestinal B lymphocytes in 6 mice with non-alcoholic fatty liver disease [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 67-73.
[2] KONG Xinxin, SUN Shuzhen, LI Qian, CHEN Yuan, ZHOU Aihua, WANG Li, YAO Xiujun. Analysis of 7 cases of anti-H factor antibody-positive hemolytic uremic syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 82-86.
[3] LUO Yingshu, LI Bin, XU Changqin, JIANG Junmei, XU Hongwei. Evaluation of the efficacy and complications of endoscopic treatment of 240 cases of upper gastrointestinal submucosal tumors [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 74-80.
[4] FU Yilin, GUO Tian, GONG Ying, YAO Zhenyu, GUAN Qingbo, XU Chao, ZHOU Xinli, ZHANG Haiqing, ZHENG Dongmei, LIU Luna, ZHAO Jiajun. Retrospective analysis of causes and clinical characteristics of 554 cases with hypokalemia in endocrinology department: a single-center study [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 39-46.
[5] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67-71.
[6] ZHAO Mengjiao, LIU Zhong, LI Zhan, CHANG Caiyun, ZHAO Xiaodong, Geng Xingyi. Epidemiological investigation of a cluster associated with corona virus disease 2019 in Jinan City, China [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 44-48.
[7] ZHOU Lin, LIU Xiaoxue, LI Zhan, GENG Xingyi, LIU Qingjie. Incidence analysis of 1 403 close contacts of corona virus disease 2019 patients in different contact modes [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 58-61.
[8] LI Shixue, SHAN Ying. Latest research advances on novel coronavirus pneumonia [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 19-25.
[9] ZHOU Shengyu, WANG Chunting, ZHANG Wei, WANG Ximing, DONG Liang. Clinical characteristics and treatment effect of 537 cases of novel coronavirus pneumonia in Shandong Province [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 44-51.
[10] CUI Liangliang, GENG Xingyi, ZHAO Xiaodong, YANG Guoliang, CHANG Caiyun, ZHAO Mengjiao, LI Zhan, WANG Chunrong, LIU Lanzheng, RUAN Shiman. Reflection and epidemiological characteristics of coronavirus disease 2019 in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 52-57.
[11] ZHANG Xiaoguo, MA Yan, XIAO Jiaan, ZHANG Zhongfa. Clinical characteristics of novel coronavirus pneumonia in children in Jinan [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 62-64.
[12] WANG Bin, BU Xuehui, KONG Xianggen, ZHANG Zhaohua, WU Anzhao, XIAO Di, JIANG Xuemei. Comparison of the clinical characteristics between 37 adults and 10 children with COVID-19 [J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 112-116.
[13] BI Tao, LU Qianqian, SUN Chuandong. Effects of adenouvirus-mediated HBx on lymphocyte in vitro [J]. Journal of Shandong University (Health Sciences), 2018, 56(7): 15-20.
[14] NIE Siyue, WANG Zhen, SUN Jingyu, LIU Jie, LI Juan, WEI Xiaojuan, LU Chunxiao, L(¨overU)Xingyan, WANG Shuyun, SUN Yuping. Expression and clinical significance of angiopoietin-like protein 5 in human gastric cancer tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 61-65.
[15] ZHENG Jin, ZHANG Jiangwei, WANG Xuzhen, KUANG Peidan, HE Xiaoli, XUE Wujun. Significance of lymphocytes and DSA monitoring for acute rejection diagnosis on the early stage of kidney transplantation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 89-94.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!